Page last updated: 2024-10-18

formaldehyde and Diabetes Mellitus, Type 2

formaldehyde has been researched along with Diabetes Mellitus, Type 2 in 8 studies

paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"A total of 166 patients diagnosed with type 2 diabetes mellitus (T2DM) were enrolled in this study."1.72TSH-SPP1/TRβ-TSH positive feedback loop mediates fat deposition of hepatocyte: Crosstalk between thyroid and liver. ( Huang, B; Wen, W; Ye, S, 2022)
"Patients with type 2 diabetes mellitus (T2DM) often develop cognitive impairments and have an increased risk of developing Alzheimer's disease."1.48Formaldehyde induces diabetes-associated cognitive impairments. ( Hamlin, JNR; Han, C; Li, H; Luo, H; Luo, W; Lv, J; Song, W; Tan, T; Tong, Z; Wan, Y; Yang, X; Zhang, Y, 2018)
"Type 2 diabetes affects over 300 million people, causing severe complications and premature death, yet the underlying molecular mechanisms are largely unknown."1.40Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. ( Akerman, İ; Berney, T; Castro, N; Cebola, I; Ferrer, J; García-Hurtado, J; Gaulton, KJ; Gloyn, AL; Gómez-Marín, C; Maestro, MA; McCarthy, MI; Miguel-Escalada, I; Morán, I; Mularoni, L; Müller, F; Nammo, T; Pasquali, L; Pattou, F; Piemonti, L; Ponsa-Cobas, J; Ravassard, P; Rodríguez-Seguí, SA; Skarmeta, JLG; Tena, JJ; van de Bunt, M, 2014)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Huang, B1
Wen, W1
Ye, S1
Thorsen, AF3
Riber, LPS3
Rasmussen, LM3
Overgaard, M3
Tan, T1
Zhang, Y3
Luo, W1
Lv, J1
Han, C1
Hamlin, JNR1
Luo, H1
Li, H1
Wan, Y1
Yang, X1
Song, W2
Tong, Z1
Winiczenko, R1
Górnicki, K1
Kaleta, A1
Janaszek-Mańkowska, M1
Khan, ZA1
Singh, C1
Khan, T1
Ganguly, M1
Bradsher, C1
Goodwin, P1
Petty, JT1
Sandau, C1
Bove, DG1
Marsaa, K1
Bekkelund, CS1
Lindholm, MG1
Salazar, J1
Bermúdez, V1
Olivar, LC1
Torres, W1
Palmar, J1
Añez, R1
Ordoñez, MG1
Rivas, JR1
Martínez, MS1
Hernández, JD1
Graterol, M1
Rojas, J1
Mubarak, Z1
Humaira, A1
Gani, BA1
Muchlisin, ZA1
Gremillet, C1
Jakobsson, JG1
Gomila, A1
Shaw, E1
Carratalà, J1
Leibovici, L1
Tebé, C1
Wiegand, I1
Vallejo-Torres, L1
Vigo, JM1
Morris, S1
Stoddart, M1
Grier, S1
Vank, C1
Cuperus, N1
Van den Heuvel, L1
Eliakim-Raz, N1
Vuong, C1
MacGowan, A1
Addy, I1
Pujol, M1
Cobb, A1
Rieger, E1
Bell, J1
Mallik, S1
Zhao, Z1
Szécsényi, Á1
Li, G1
Gascon, J1
Pidko, EA1
Zhang, GR1
Wolker, T1
Sandbeck, DJS1
Munoz, M1
Mayrhofer, KJJ1
Cherevko, S1
Etzold, BJM1
Lukashuk, L1
Yigit, N1
Rameshan, R1
Kolar, E1
Teschner, D1
Hävecker, M1
Knop-Gericke, A1
Schlögl, R1
Föttinger, K1
Rupprechter, G1
Franconieri, F1
Deshayes, S1
de Boysson, H1
Trad, S1
Martin Silva, N1
Terrier, B1
Bienvenu, B1
Galateau-Sallé, F1
Emile, JF1
Johnson, AC1
Aouba, A1
Vogt, TJ1
Gevensleben, H1
Dietrich, J1
Kristiansen, G1
Bootz, F1
Landsberg, J1
Goltz, D1
Dietrich, D1
Idorn, M1
Skadborg, SK1
Kellermann, L1
Halldórsdóttir, HR1
Holmen Olofsson, G1
Met, Ö1
Thor Straten, P1
Johnson, LE1
Brockstedt, D1
Leong, M1
Lauer, P1
Theisen, E1
Sauer, JD1
McNeel, DG1
Morandi, F1
Marimpietri, D1
Horenstein, AL1
Bolzoni, M1
Toscani, D1
Costa, F1
Castella, B1
Faini, AC1
Massaia, M1
Pistoia, V1
Giuliani, N1
Malavasi, F1
Qiu, J1
Peng, S1
Yang, A1
Ma, Y1
Han, L1
Cheng, MA1
Farmer, E1
Hung, CF1
Wu, TC1
Modak, S1
Le Luduec, JB1
Cheung, IY1
Goldman, DA1
Ostrovnaya, I1
Doubrovina, E1
Basu, E1
Kushner, BH1
Kramer, K1
Roberts, SS1
O'Reilly, RJ1
Cheung, NV1
Hsu, KC1
Salgarello, T1
Giudiceandrea, A1
Calandriello, L1
Marangoni, D1
Colotto, A1
Caporossi, A1
Falsini, B1
Lefrançois, P1
Xie, P1
Wang, L2
Tetzlaff, MT1
Moreau, L1
Watters, AK1
Netchiporouk, E1
Provost, N1
Gilbert, M1
Ni, X1
Sasseville, D1
Wheeler, DA1
Duvic, M1
Litvinov, IV1
O'Connor, BJ1
Fryda, NJ1
Ranglack, DH1
Yang, Y2
Yang, J1
Zhang, X2
Grün, AL1
Emmerling, C1
Aumeeruddy-Elalfi, Z1
Ismaël, IS1
Hosenally, M1
Zengin, G1
Mahomoodally, MF1
Dotsenko, A1
Gusakov, A1
Rozhkova, A1
Sinitsyna, O1
Shashkov, I1
Sinitsyn, A1
Hong, CE1
Kim, JU1
Lee, JW1
Lee, SW1
Jo, IH1
Pandiyarajan, S1
Premasudha, P1
Kadirvelu, K1
Wang, B1
Luo, L1
Wang, D1
Ding, R1
Hong, J1
Caviezel, D1
Maissen, S1
Niess, JH1
Kiss, C1
Hruz, P1
Pockes, S1
Wifling, D1
Keller, M1
Buschauer, A1
Elz, S1
Santos, AF1
Ferreira, IP1
Pinheiro, CB1
Santos, VG1
Lopes, MTP1
Teixeira, LR1
Rocha, WR1
Rodrigues, GLS1
Beraldo, H1
Lohar, S1
Dhara, K1
Roy, P1
Sinha Babu, SP1
Chattopadhyay, P1
Sukwong, P1
Sunwoo, IY1
Lee, MJ1
Ra, CH1
Jeong, GT1
Kim, SK2
Huvinen, E1
Eriksson, JG1
Stach-Lempinen, B1
Tiitinen, A1
Koivusalo, SB1
Malhotra, M1
Suresh, S1
Garg, A1
Wei, L1
Jiang, Y2
Zhou, W1
Liu, S1
Liu, Y1
Rausch-Fan, X1
Liu, Z1
Marques, WL1
van der Woude, LN1
Luttik, MAH1
van den Broek, M1
Nijenhuis, JM1
Pronk, JT1
van Maris, AJA1
Mans, R1
Gombert, AK1
Xu, A1
Sun, J1
Li, J1
Chen, W2
Zheng, R1
Han, Z1
Ji, L1
Shen, WQ1
Bao, LP1
Hu, SF1
Gao, XJ1
Xie, YP1
Gao, XF1
Huang, WH1
Lu, X1
Gostin, PF1
Addison, O1
Morrell, AP1
Cook, AJMC1
Liens, A1
Stoica, M1
Ignatyev, K1
Street, SR1
Wu, J1
Chiu, YL1
Davenport, AJ1
Qiu, Z1
Shu, J1
Tang, D1
Gao, X1
Zhang, J3
Huang, K1
Wai, H1
Du, K1
Anesini, J1
Kim, WS1
Eastman, A1
Micalizio, GC1
Liang, JH1
Huo, XK1
Cheng, ZB1
Sun, CP1
Zhao, JC1
Kang, XH1
Zhang, TY1
Chen, ZJ1
Yang, TM1
Wu, YY1
Deng, XP1
Zhang, YX1
Salem, HF1
Kharshoum, RM1
Abou-Taleb, HA1
AbouTaleb, HA1
AbouElhassan, KM1
Ohata, C1
Ohyama, B1
Kuwahara, F1
Katayama, E1
Nakama, T1
Kobayashi, S1
Kashiwagi, T1
Kimura, J1
Lin, JD1
Liou, MJ1
Hsu, HL1
Leong, KK1
Chen, YT1
Wang, YR1
Hung, WS1
Lee, HY1
Tsai, HJ1
Tseng, CP1
Alten, B1
Yesiltepe, M1
Bayraktar, E1
Tas, ST1
Gocmen, AY1
Kursungoz, C1
Martinez, A1
Sara, Y1
Huang, S2
Adams, E1
Van Schepdael, A1
Wang, Q1
Chung, CY1
Yang, W1
Yang, G1
Chough, S1
Chen, Y1
Yin, B1
Bhattacharya, R1
Hu, Y1
Saeui, CT1
Yarema, KJ1
Betenbaugh, MJ1
Zhang, H1
Patik, JC1
Tucker, WJ1
Curtis, BM1
Nelson, MD1
Nasirian, A1
Park, S1
Brothers, RM1
Dohlmann, TL1
Hindsø, M1
Dela, F1
Helge, JW1
Larsen, S1
Gayani, B1
Dilhari, A1
Wijesinghe, GK1
Kumarage, S1
Abayaweera, G1
Samarakoon, SR1
Perera, IC1
Kottegoda, N1
Weerasekera, MM1
Nardi, MV1
Timpel, M1
Ligorio, G1
Zorn Morales, N1
Chiappini, A1
Toccoli, T1
Verucchi, R1
Ceccato, R1
Pasquali, L3
List-Kratochvil, EJW1
Quaranta, A1
Dirè, S1
Heo, K1
Jo, SH1
Shim, J1
Kang, DH1
Kim, JH1
Park, JH1
Akhtar, N1
Saha, A1
Kumar, V1
Pradhan, N1
Panda, S1
Morla, S1
Kumar, S1
Manna, D1
Wang, H1
Xu, E1
Yu, S1
Li, D1
Quan, J1
Xu, L1
Saslow, SA1
Um, W1
Pearce, CI1
Bowden, ME1
Engelhard, MH1
Lukens, WL1
Kim, DS1
Schweiger, MJ1
Kruger, AA1
Adair, LS1
Kuzawa, C1
McDade, T1
Carba, DB1
Borja, JB1
Liang, X2
Wang, K1
Zhang, B1
Peele, ME1
Luo, HR1
Chen, ZY1
Fei, JJ1
Du, ZJ1
Yi, KJ1
Im, WT1
Kim, DW1
Ji, X1
Zhang, C1
Xu, Z1
Ding, Y1
Song, Q1
Li, B2
Zhao, H1
Lee, DW1
Lee, H1
Kwon, BO1
Khim, JS1
Yim, UH1
Park, H1
Park, B1
Choi, IG1
Kim, BS1
Kim, JJ1
Wang, JJ1
Chen, Q1
Li, YZ1
Sakai, M1
Yamaguchi, M1
Nagao, Y1
Kawachi, N1
Kikuchi, M1
Torikai, K1
Kamiya, T1
Takeda, S1
Watanabe, S1
Takahashi, T1
Arakawa, K1
Nakano, T1
Rufo, S1
Continentino, MA1
Nikolaou, V1
Plass, F1
Planchat, A1
Charisiadis, A1
Charalambidis, G1
Angaridis, PA1
Kahnt, A1
Odobel, F1
Coutsolelos, AG1
Fuentes, I1
García-Mendiola, T1
Sato, S1
Pita, M1
Nakamura, H1
Lorenzo, E1
Teixidor, F1
Marques, F1
Viñas, C1
Liu, F1
Qi, P1
Zhang, L1
Gaulton, KJ2
Rodríguez-Seguí, SA1
Mularoni, L1
Miguel-Escalada, I1
Akerman, İ1
Tena, JJ1
Morán, I1
Gómez-Marín, C1
van de Bunt, M1
Ponsa-Cobas, J1
Castro, N1
Nammo, T2
Cebola, I1
García-Hurtado, J1
Maestro, MA1
Pattou, F1
Piemonti, L1
Berney, T2
Gloyn, AL1
Ravassard, P1
Skarmeta, JLG1
Müller, F1
McCarthy, MI1
Ferrer, J2
Simon, JM1
Giresi, PG1
Fogarty, MP1
Panhuis, TM1
Mieczkowski, P1
Secchi, A1
Bosco, D1
Montanya, E1
Mohlke, KL1
Lieb, JD1
Lertsiri, S1
Oak, JH1
Nakagawa, K1
Miyazawa, T1
Takeshita, N1
Yamaguchi, I1

Trials

1 trial available for formaldehyde and Diabetes Mellitus, Type 2

ArticleYear
    Neural computing & applications, 2018, Volume: 30, Issue:6

    Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosp

2018

Other Studies

7 other studies available for formaldehyde and Diabetes Mellitus, Type 2

ArticleYear
TSH-SPP1/TRβ-TSH positive feedback loop mediates fat deposition of hepatocyte: Crosstalk between thyroid and liver.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Animals; Biomarkers; Diabetes Mellitus, Type 2; Feedback; Formaldehyde; Hepatocytes; Humans; Lipids;

2022
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue.
    Journal of proteomics, 2023, 02-10, Volume: 272

    Topics: Arteries; Diabetes Mellitus, Type 2; Formaldehyde; Humans; Paraffin Embedding; Proteins; Tandem Mass

2023
Formaldehyde induces diabetes-associated cognitive impairments.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:7

    Topics: Aged; Aldehyde Dehydrogenase, Mitochondrial; Animals; Cognitive Dysfunction; Diabetes Mellitus, Type

2018
Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants.
    Nature genetics, 2014, Volume: 46, Issue:2

    Topics: Base Sequence; Chromatin; Chromatin Immunoprecipitation; Diabetes Mellitus, Type 2; Electrophoretic

2014
A map of open chromatin in human pancreatic islets.
    Nature genetics, 2010, Volume: 42, Issue:3

    Topics: Binding Sites; Cells, Cultured; Chromatin; Chromatin Assembly and Disassembly; Chromosome Mapping; D

2010
The occurrence of a novel hydrophilic hydroperoxide, 3-hydroxy-5-hydroperoxy-2-methyl-5,6-dihydropyran-4-one, as a reactive glycation product in human plasma.
    Biochimica et biophysica acta, 2002, Oct-10, Volume: 1573, Issue:1

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Electrophoresis, Polyacrylamide Gel; Formaldehyde; Glycate

2002
Meta-chlorophenylpiperazine attenuates formalin-induced nociceptive responses through 5-HT1/2 receptors in both normal and diabetic mice.
    British journal of pharmacology, 1995, Volume: 116, Issue:8

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Formaldehyde; Indoles; Ketanser

1995